[血栓动力学方法和常规血液静止测试在慢性淋巴结膜炎中高凝血综合征的评估中的比较]
N V Chebotareva1, E A Kharionovskaya1, E A Biryukova1
1Sechenov First Moscow State Medical University (Sechenov University).
Terapevticheskii arkhiv
|August 6, 2024
概括
与常规测试相比,脏综合征患者在血栓动力学 (TD) 测试中显示出更高的高凝血能力. 自发血块的DT检测测试表明慢性瘤炎中血栓栓塞事件的风险较高.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 性综合征 (NS) 显著增加了血栓性并发症的风险.
- 常规的血液静止测试不足以评估NS患者的高凝血状态.
- 全球功能性血液静止测试,如血栓动力学 (TD),显示出评估凝血障碍的前景.
研究的目的:
- 在慢性淋巴结膜炎 (CGN) 患者中,比较常规测试和TD之间的高凝血率.
- 确定与CGN患者血栓形成风险增加相关的因素.
- 评估TD在预测血栓栓塞事件中的实用性.
主要方法:
- 包括94名具有活性CGN的患者 (63名具有NS,31名没有).
- 使用常规凝血测试和TD测试评估血静.
- 使用后勤回归来分析血栓形成风险因素.
主要成果:
- 通过TD检测的高凝血率:53.9%在NS与32.2%没有NS (p<0.05).
- 常规测试显示,高凝血率为9.5%与NS相比9.7%没有NS (p<0.05).
- 在TD上自发凝块形成与年龄较大,脂质较高,葡萄糖皮质类固醇和血栓栓塞事件有关.
结论:
- 与常规测试 (9.5%) 相比,TD测试显示,NS (53.9%) 的CGN患者的高凝血能力显著更高.
- 自发血块的TD检测测试检测是血栓栓塞事件的重要预测指标.
- 常规检测低估了NS患者的高凝血和血栓风险.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
01:24Disorders of Hemostasis
768
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
768
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.7K